Category archives for: Stocks

Director of Alto Ingredients, Inc. (NASDAQ:ALTO), Nathan Gilbert E, buys 15,000 shares worth $92,248

According to Alto Ingredients, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Jun 14 07:30 AM, company Director, Nathan Gilbert E disclosed buying 15,000 shares at a cost of $6.15. At the time of this transaction (Jun 10), this trade was worth $92,248 in total. As […]

President, CFO and COO of SONIM TECHNOLOGIES INC (NASDAQ:SONM), Tirva Robert L., sells 42,891 shares worth $27,450

According to SONIM TECHNOLOGIES INC’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Jun 11 09:30 PM, company President, CFO and COO, Tirva Robert L. disclosed selling 42,891 shares at a cost of $0.64. At the time of this transaction (Jun 10), this trade was worth $27,450 […]

Director of SYNNEX CORP (NYSE:SNX), Murai Kevin M, sells 4,275 shares worth $541,586

According to SYNNEX CORP’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Jun 11 09:20 PM, company Director, Murai Kevin M disclosed selling 4,275 shares at a cost of $126.69. At the time of this transaction (Jun 10), this trade was worth $541,586 in total. As of […]

See Remarks of DraftKings Inc. (NASDAQ:DKNG), Kalish Matthew, sells 57,692 shares worth $3,097,092

According to DraftKings Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Jun 11 09:09 PM, company See Remarks, Kalish Matthew disclosed selling 57,692 shares at a cost of $53.68. At the time of this transaction (Jun 11), this trade was worth $3,097,092 in total. As of […]

Chief Legal Officer of DraftKings Inc. (NASDAQ:DKNG), Dodge R Stanton, sells 50,588 shares worth $2,715,870

According to DraftKings Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Jun 11 09:08 PM, company Chief Legal Officer, Dodge R Stanton disclosed selling 50,588 shares at a cost of $53.69. At the time of this transaction (Jun 11), this trade was worth $2,715,870 in total. […]

EVP and General Counsel of Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), Parschauer Karah Herdman, sells 1,329 shares worth $132,900

According to Ultragenyx Pharmaceutical Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Jun 11 09:08 PM, company EVP and General Counsel, Parschauer Karah Herdman disclosed selling 1,329 shares at a cost of $100.00. At the time of this transaction (Jun 10), this trade was worth $132,900 […]

See Remarks of DraftKings Inc. (NASDAQ:DKNG), Liberman Paul, sells 85,000 shares worth $4,548,170

According to DraftKings Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Jun 11 09:08 PM, company See Remarks, Liberman Paul disclosed selling 85,000 shares at a cost of $53.51. At the time of this transaction (Jun 10), this trade was worth $4,548,170 in total. As of […]

President & CEO of Atlanticus Holdings Corp (NASDAQ:ATLC), Howard Jeffrey A., sells 9,025 shares worth $361,000

According to Atlanticus Holdings Corp’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Jun 11 09:02 PM, company President & CEO, Howard Jeffrey A. disclosed selling 9,025 shares at a cost of $40.00. At the time of this transaction (Jun 09), this trade was worth $361,000 in […]

Chief Scientific Officer of Adaptive Biotechnologies Corp (NASDAQ:ADPT), Robins Harlan S, sells 3,895 shares worth $149,607

According to Adaptive Biotechnologies Corp’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Jun 11 09:00 PM, company Chief Scientific Officer, Robins Harlan S disclosed selling 3,895 shares at a cost of $38.41. At the time of this transaction (Jun 11), this trade was worth $149,607 in […]

Chief Scientific Officer of Adaptive Biotechnologies Corp (NASDAQ:ADPT), Robins Harlan S, sells 3,895 shares worth $146,294

According to Adaptive Biotechnologies Corp’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Jun 11 09:00 PM, company Chief Scientific Officer, Robins Harlan S disclosed selling 3,895 shares at a cost of $37.56. At the time of this transaction (Jun 10), this trade was worth $146,294 in […]

Featured Press Releases

Photo Gallery

Log in